Understanding the EU FMD is no easy task, but this law has had a significant impact throughout the pharmaceutical and healthcare industries, affecting operations from one end of the supply chain to the other, from manufacturing to dispensing.
Pharmaceutical manufacturers, parallel importers and contract manufacturing organisations (CMOs) must guarantee the authenticity of all prescription drugs by identifying individual packs and checking whether the outer packaging of medicines has been tampered with.
Wholesalers and distributors must guarantee the authenticity of prescription drugs and identify whether the outer packaging of medicines has been altered.
European hospitals and retail pharmacies are then be required to decommission prescription medications using unique identifiers before distributing them to patients.
